1. Perel JM, Jann MW (2006) Antipsychotics. In: Burton ME, Shaw LM, Schentag JJ, Evans WE (eds). Applied pharmacokinetics and pharmacodynamics – principles of therapeutic drug monitoring, 4th ed. Philadelphia, Lippincott Williams and Wilkins. pp 813–838
2. Jorgensen A (1986) Metabolism and pharmacokinetics of antipsychotics. In: Bridges JW, Chasseaud LF (eds) Progress in drug metabolism, vol 9. Taylor, and Francis, London, pp 111–174
3. Moons T, de Roo M, Clees S, Dom G (2011) Relationship between P-glycoprotein and second generation antipsychotics. Pharmacogenomics 12:1193–1211
4. Mauri MC, Volonteri LS, Colasanti A, Fiorentino A, De Gaspari IF, Bareggi SR (2007) Clinical pharmacokinetics of atypical antipsychotics. Clin Pharmacokinet 46:359–388
5. Sheehan JJ, Sliwa JK, Amatniek JC, Grinspan A, Canuso CM (2010) Atypical antipsychotic metabolism and excretion. Curr Drug Metab 11:516–525